Status: current, Defined. Date: 31-Aug 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4448201000168114 | epinephrine acid tartrate 9 mg / 5 mL + lidocaine hydrochloride monohydrate 212 mg / 5 mL + tetracaine hydrochloride 25 mg / 5 mL solution, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4448211000168112 | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | Is a | adrenaline (epinephrine) + tetracaine (amethocaine) + lidocaine | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has manufactured dose form | solution | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has unit of use | vial | true | Inferred relationship | Some | 1399023115 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has Australian BoSS | lidocaine hydrochloride monohydrate | true | Inferred relationship | Some | 1430571618 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 1430571618 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has intended active ingredient | tetracaine (amethocaine) | true | Inferred relationship | Some | 775094296 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has Australian BoSS | tetracaine hydrochloride (AU substance) | true | Inferred relationship | Some | 775094296 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has Australian BoSS | adrenaline (epinephrine) acid tartrate | true | Inferred relationship | Some | 1720930896 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | has intended active ingredient | adrenaline (epinephrine) | true | Inferred relationship | Some | 1720930896 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Is a | True | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | Inferred relationship | Some | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, 5 x 5 mL vials | has MPUU | True | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | Inferred relationship | Some | 294739692 |
Reference Sets
Medicinal product unit of use reference set
FHIR